Catalent Clinical Supply Services Enhances Direct Global Comparator Sourcing Network

Global Network of Specialists Enhances Its Full Range of Clinical Supply Services to Ensure Reliable Supply, Timely Delivery and Competitive Pricing for Comparator Drug Sourcing

Jan 17, 2011 - SOMERSET, NJ - Catalent Pharma Solutions, a leading provider of pharmaceutical services from drug and biologic development to delivery technologies to supply solutions, announced that it is enhancing a global network of Catalent sourcing specialists to supply comparator drugs directly from manufacturers, thereby reducing customer costs and ensuring timely initiation and reliability of product supply.

"Issues pertaining to supply chain management, such as reliability, pricing and security, often threaten to undermine the success of a clinical study," said Frank Lis, Vice President and General Manager, Clinical Supply Services, Catalent Pharma Solutions. "In assembling this global network of comparator sourcing specialists, we aim to provide our clinical trials customers with the highest-quality supply, as well as competitive prices, fast procurement and a minimized risk of project delay and counterfeit products."

The network's sourcing specialists will cultivate a select group of leading innovators, manufacturers, and quality assurance professionals to access virtually any product in the world, and to identify the most cost-effective options for trial sponsors. Specialists will have access to Catalent's comprehensive range of Clinical Supply Services, from manufacturing to packaging to distributing product directly to the clinical sites.  This flexibility provides customers with improved support and control over the full sourcing process.

To learn more about Catalent's direct comparator sourcing network, visit the Catalent booth at the upcoming Center for Business Intelligence's Inaugural European Conference on Comparator Studies, January 19-20 at the Hilton London Paddington Hotel in London, UK, or visit http://www.catalent.com/pharma/clinical-supply-services.php.

# # #

About Catalent
From drug and biologic development services to delivery technologies to supply solutions, Catalent Pharma Solutions has the deepest expertise, the broadest offerings and the most unique technologies in the industry. With over 75 years of experience, Catalent helps customers get more molecules to market faster, enhance product performance, and provide superior, reliable manufacturing and packaging solutions. Catalent employs approximately 9,000 people at 29 facilities worldwide and in fiscal year 2010 generated more than $1.7 billion in annual revenue. Catalent is headquartered in Somerset, NJ. For more information, visit http://www.catalent.com.

Suggested Articles

Saturday, AstraZeneca revealed more of the data that convinced the FDA to green-light Calquence in previously untreated chronic lymphocytic leukemia.

The efficacy between Keytruda and FerGene's nadofaragene firadenovec look comparable in their studies, though Merck has at least one upper hand.

Thursday, the FDA approved the first three generic versions of Gilenya, but they may not hit the market anytime soon due to ongoing litigation.